Evolving Strategies Using BTK Inhibitors in CLL: A Selective Approach to Improve Patient Outcomes

Hear from the experts on how the latest clinical data inform the use of BTK inhibitors in the treatment of CLL. Review their insights in an on-demand webcast adapted from a live webinar along with downloadable slidesets 2 commentaries and a podcast.

Share

Program Content

No activities added yet

No activities added yet

No activities added yet

Provided by

ProCE Banner

Supporters

Supported by an educational grant from

AstraZeneca